Eurecat   Report issue

For profit
Founded: Barcelona Spain (2015)
Status: No NME R&D (2015)

Organization Overview

First Clinical Trial
2019
NCT03984916
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Eurecat | Fundació Eurecat | UTNS (Eurecat_Reus) | UTNS (Eurecat-Reus) | UTNS (Eurecat_Reus)/HUSJR. Reus, Tarragona. Spain.

Active Ingredients

Drugs in Other Trials (2)

aged garlic extract (1 trial)

hesperidin (1 trial)

Indications

Overview

  • Highest Phase: Phase 0
  • # of Trials: 6
  • # of Trial APIs: 2